Form 4: Surgery Partners National Group President Acquires Shares Following Performance Vesting

Sentiment:

SEC Form 4 Filing


Harrison R. Bane, National Group President of Surgery Partners, Inc., acquired 115,116 shares of common stock on January 31, 2025, following the satisfaction of performance vesting criteria.

Summary

  • On January 31, 2025, Harrison R. Bane, the National Group President of Surgery Partners, Inc., acquired 115,116 shares of common stock.
  • The acquisition was a result of performance stock unit awards granted on September 1, 2022, that vested based on performance criteria over the three-year period ending December 31, 2024.
  • The shares vested immediately upon certification by the Board on January 31, 2025.
  • Following the transaction, Bane directly owns 163,352 shares of Surgery Partners, Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The vesting of performance-based equity suggests the company met certain performance goals. The insider's increased stake could signal confidence, but it's a routine filing.

Positives

  • The vesting of performance stock units suggests that the company met certain performance targets, which is a positive indicator.
  • The acquisition of shares by a company executive can be seen as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted performance-based equity awards, which is a common practice in the healthcare industry to align executive compensation with company performance.

Comparison to Industry Standards

  • Performance-based equity compensation is a common practice among publicly traded healthcare companies like Surgery Partners.
  • Companies such as HCA Healthcare and Tenet Healthcare also utilize performance-based equity awards to incentivize their executives.
  • The vesting criteria for these awards typically involve metrics such as revenue growth, profitability, and patient satisfaction scores.

Stakeholder Impact

  • Shareholders may view the vesting of performance-based equity as a positive sign, indicating that management is incentivized to achieve company goals.
  • Employees may see this as a reflection of the company's success and their contributions to it.

Key Dates

DateDescription
September 1, 2022Date of grant for performance stock unit awards to the Reporting Person.
December 31, 2024End of the three-year performance period for the performance stock unit awards.
January 31, 2025Date of transaction and Board certification of performance vesting.
February 04, 2025Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.